Cholesterol control supplements sales will strengthen through 2036, anchored by cholesterol control supplements at a 34.0% share in 2026 as the leading product segment. The market is expected to reach USD 1.2 billion in 2026 and USD 1.8 billion by 2036, creating an absolute dollar opportunity of USD 0.6 billion.